Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Familial combined hyperlipidemia]

G Martin1, I Shviro, B Staels

  • 1U325 INSERM, Département d'Athérosclérose, Institut Pasteur, Lille.

Annales D'Endocrinologie
|January 1, 1997
PubMed
Summary

Familial combined hyperlipidemia is an inherited condition causing high levels of apo B particles and increasing atherosclerosis risk. Treatment focuses on reducing harmful lipoproteins and enhancing triglyceride clearance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased 1-deoxysphingolipids caused by an altered plasma alanine to serine ratio are associated with metabolic dysfunction-associated steatotic liver disease (MASLD).

Metabolomics : Official journal of the Metabolomic Society·2025
Same author

Role of bile acid receptor FXR in development and function of brown adipose tissue.

Biochimica et biophysica acta. Molecular and cell biology of lipids·2022
Same author

[State of the art on the pathophysiology, diagnosis and treatment of non-alcoholic steatohepatitis (NASH)].

Annales pharmaceutiques francaises·2022
Same author

Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease.

Acta diabetologica·2020
Same author

Best Poster Award - Second Prize: Bile Acids as Novel Vascular Signalling Molecules and Therapeutic Target.

European cardiology·2020
Same author

Peroxisome Proliferator-Activated Receptor <i>γ</i> Induces the Expression of Tissue Factor Pathway Inhibitor-1 (TFPI-1) in Human Macrophages.

PPAR research·2017

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Metabolic Disorders

Context:

  • Familial combined hyperlipidemia (FCH) is a prevalent inherited lipid disorder.
  • Characterized by hepatic overproduction of apolipoprotein B (apo B) particles.
  • Associated with an increased risk of atherosclerosis development.

Purpose:

  • To summarize the key features of familial combined hyperlipidemia.
  • To highlight the role of apo B overproduction and LDL particle characteristics.
  • To outline current treatment goals for managing the condition.

Summary:

  • FCH involves smaller, denser LDL particles prone to oxidation.
  • The precise pathogenesis remains incompletely understood.
  • Treatment strategies aim to decrease atherogenic lipoprotein synthesis and boost triglyceride-rich lipoprotein clearance.

Impact:

  • Understanding FCH pathogenesis is crucial for targeted therapies.
  • Effective management can mitigate atherosclerosis risk.
  • Further research may elucidate novel treatment approaches for this common inherited disorder.

Related Experiment Videos